Your Good Partner in Biology Research

  1. 首页
  2. 试剂盒
  3. 酶联免疫试剂盒
  4. Human Interleukin 37(IL-37) ELISA Kit

Human Interleukin 37(IL-37) ELISA Kit

  • 中文名称：
    人白介素37(IL-37)酶联免疫试剂盒
  • 货号：
    CSB-E16185h
  • 规格：
    96T/48T
  • 价格：
    ￥3600/￥2500
  • 其他：

产品详情

  • 产品描述：

    This human IL-37 ELISA Kit is suitable for qualitatively determining human concentrations in multiple biological fluids, including human serum, plasma, and tissue homogenates in vitro. IL-37 plays an important role in innate and adaptive immunity and may be a useful molecule for effective cytokine therapy. During inflammation, IL-37 inhibits the expression of several pro-inflammatory cytokines to facilitate the expression of the anti-inflammatory ones by regulating macrophage polar. In addition to modulating innate and acquired immunity, IL-37 also improves aging-associated immunosenescence. Furthermore, IL-37 exhibits an inhibitory effect on tumor angiogenesis and metastasis and progression.

    This kit uses the quantitative sandwich-based enzyme immunoassay technique to measure the amount of human IL-37 in the sample. Standards and samples are respectively added to the microplate wells pre-coated with an anti-human IL-37 antibody. Biotin-labeled IL-37 antibody, HRP-avidin, and TMB substrate are pipped into the microplate in turn. The capture antibody pre-coated on the plate captures the IL-37n in the human samples. IL-37 binds to the biotinylated anti-IL-37 human monoclonal antibody. And the biotin on the biotinylated anti-IL-37 human monoclonal antibody binds to the avidin on the enzyme label, forming immune complexes. The color renders blue after the addition of the TMB substrate. The addition of the stop solution into the wells immediately turns the blue into yellow. The concentration of IL-37 in the samples is directly proportional to OD (450nm). Each manufactured lot of this ELISA kit was quality tested for criteria such as sensitivity, specificity, precision, linearity, and lot-to-lot consistency.

  • 别名：
    FIL1 ELISA Kit; FIL1 zeta ELISA Kit; FIL1(ZETA) ELISA Kit; FIL1Z ELISA Kit; IL 1 zeta ELISA Kit; IL 1F7 ELISA Kit; IL 1F7b (IL 1H4; IL 1H; IL 1RP1) ELISA Kit; IL 1H4 ELISA Kit; IL 1RP1 ELISA Kit; IL 1X ELISA Kit; IL 1X protein ELISA Kit; IL-1 zeta ELISA Kit; IL-1F7 ELISA Kit; IL-1H ELISA Kit; IL-1H4 ELISA Kit; IL-1RP1 ELISA Kit; IL-1X ELISA Kit; IL-37 ELISA Kit; IL1F7 (canonical product IL 1F7b) ELISA Kit; IL1F7 ELISA Kit; IL1F7_HUMAN ELISA Kit; IL1H4 ELISA Kit; IL1RP1 ELISA Kit; Interleukin 1 family member 7 ELISA Kit; interleukin 1 family; member 7 (zeta) ELISA Kit; Interleukin 1 homolog 4 ELISA Kit; Interleukin 1 related protein ELISA Kit; Interleukin 1 superfamily z ELISA Kit; Interleukin 1 zeta ELISA Kit; Interleukin 37 ELISA Kit; Interleukin-1 family member 7 ELISA Kit; Interleukin-1 homolog 4 ELISA Kit; Interleukin-1 zeta ELISA Kit; Interleukin-1-related protein ELISA Kit; Interleukin-23 ELISA Kit
  • 缩写：
    IL1F7
  • Uniprot No.：
  • 种属：
    Homo sapiens (Human)
  • 样本类型：
    serum, plasma, cell culture supernates
  • 检测范围：
    31.25 pg/mL-2000 pg/mL
  • 灵敏度：
    7.81 pg/mL
  • 反应时间：
    1-5h
  • 样本体积：
    50-100ul
  • 检测波长：
    450 nm
  • 研究领域：
    Immunology
  • 测定原理：
    quantitative
  • 测定方法：
    Sandwich
  • 精密度：
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 线性度：
    To assess the linearity of the assay, samples were spiked with high concentrations of human IL-37 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    　SampleSerum(n=4)
    1:1Average %87
    Range %81-93
    1:2Average %85
    Range %80-92
    1:4Average %95
    Range %90-100
    1:8Average %98
    Range %88-103
  • 回收率：
    The recovery of human IL-37 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9286-100
    EDTA plasma (n=4)9484-98
  • 标准曲线：
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/mlOD1OD2AverageCorrected
    20001.654 1.605 1.630 1.468
    10001.219 1.233 1.226 1.064
    5000.854 0.892 0.873 0.711
    2500.562 0.581 0.572 0.410
    1250.359 0.379 0.369 0.207
    62.50.268 0.280 0.274 0.112
    31.250.218 0.213 0.216 0.054
    00.165 0.159 0.162 　
  • 数据处理：
  • 货期：
    3-5 working days

引用文献

产品评价

靶点详情

  • 功能：
    Suppressor of innate inflammatory and immune responses involved in curbing excessive inflammation. This function requires SMAD3. Suppresses, or reduces, proinflammatory cytokine production, including IL1A and IL6, as well as CCL12, CSF1, CSF2, CXCL13, IL1B, IL23A and IL1RN, but spares anti-inflammatory cytokines. Inhibits dendritic cell activation.
  • 基因功能参考文献：
    1. a genome wide association study for "high" gingival crevicular fluid IL-1beta expression among 4910 European-American adults and identify association signals in the IL37 locus, is reported. PMID: 30206230
    2. IL-37 can be secreted extracellularly, and binds to IL-18Ra chain and recruits Toll/IL-1R (TIR)-8 for transducing anti-inflammatory signaling. IL-37 is upregulated in an inducible manner and negatively regulates signaling mediated by TLR agonists and pro-inflammatory cytokines. PMID: 28548248
    3. Our results showed that IL-37 plays an inhibitory role in non-small cell lung cancer progression, possibly by suppressing STAT3 activation and decreasing epithelial-to-mesenchymal transition by inhibiting IL-6 expression. IL-37 could serve as a potential novel tumor suppressor in non-small cell lung cancer PMID: 29575809
    4. TIM-3 and IL-37 may be used as potential biomarkers of active rheumatoid arthritis. PMID: 30106887
    5. This study suggests that human IL-37 overexpressed in mice reduces lean body mass by reducing food intake. PMID: 30072596
    6. These data suggest that IL37 is a new susceptibility gene for Coronary artery disease (CAD), which provides a potential target for the prevention and treatment of CAD PMID: 28181534
    7. In allergic rhinits patients, the IL-1R8 ligand IL-37 could potentially modulate aberrant immune responses by attenuating IL-17 and IL-4 production by CD4+ T cells. PMID: 29730558
    8. Review of role of interleukin 37 in physiology and disease. PMID: 29805973
    9. this study shows that Interleukin-37 alleviates airway inflammation and remodeling in asthma via inhibiting the activation of NF-kappaB and STAT3 signalings PMID: 29268192
    10. IL1F7 gene polymorphism does not significantly influence rheumatoid arthritis susceptibility in the Northern Chinese Han population. PMID: 29336365
    11. IL37 may be an important cytokine in the pathogenesis of allergic rhinitis. PMID: 29115624
    12. results suggest that there was a low level of interleukin 37 in the eutopic and ectopic endometria of patients with adenomyosis PMID: 28762845
    13. Study concludes that recombinant human interleukin-37 enhances the suppressive activity of CD4(+)CD25(+) regulatory T cells and might be a potential immunomodulator for the treatment of septic complications. PMID: 27941849
    14. IL-37 level is elevated in systemic lupus erythematous patients in comparison to healthy controls and is correlated to high disease activity, mucocutaneous and renal involvement. PMID: 28627005
    15. An association of IL-37 single nucleotide polymorphism rs3811047 with Behcet's disease, but not Vogt-Koyanagi-Harada disease in Han Chinese. PMID: 27775096
    16. The data suggest that IL-10, but not IL-37, may have potential as a biomarker predictive for disease activity in Systemic lupus erythematosus. PMID: 27708376
    17. this study shows that IL-37 causes excessive inflammation and tissue damage in murine pneumococcal pneumonia PMID: 28601872
    18. common genetic variants of IL37 lead to different immune-inhibitory potencies. PMID: 27665946
    19. IL-37 increased from normal control (NC) to oral leukoplakia (OLK) and oral squamous cell carcinoma (OSCC). IL-37 expression was lower in OSCC with lymph node metastasis than those without metastasis. IL-37 overexpression in RAW264.7 cells remarkably reduced the pseudopodia, vacuolization and the expression of IL-6, TNF-alpha, and IL-1beta. IL-37 and IL-18Ralpha but not IL-18BP have similar expression and location in ... PMID: 27225603
    20. We conclude that under low-grade inflammatory conditions, hematopoietic IL-37 expression reduces the inflammatory state, but does not influence atherosclerosis development in hyperlipidemic LDLr-deficient mice. PMID: 28792474
    21. The IL- 37 (rs3811047) polymorphism contributes to the development of ADs in a Chinese population. PMID: 29642198
    22. IL-37 is produced primarily by CD4+ T cells and vascular smooth muscle cells and that it plays a protective role in atherosclerotic injury by directing a switch in CD4+ T lymphocyte phenotypes in addition to directly regulating the expression of caspase-3 to reduce H2O2- and pro-inflammatoryinduced SMC apoptosis. PMID: 29439249
    23. Blocking IL-1 with IL-37 alleviates the symptoms in patients with inflammatory diseases including arteriosclerosis. The impact of IL-37 on inflammatory cytokines mediating atherosclerosis is beneficial and protective. PMID: 28420489
    24. these data highlight the importance of IL-37 in the cell proliferation and progression of hepatocellular carcinoma PMID: 27835881
    25. Serum Il-37 level is significantly increased in acute coronary syndrome. IL-37 may exert a cardioprotective effect by suppressing ROCK activity. PMID: 28039466
    26. this study found that IL-37 levels in peritoneal fluid and in serum were significantly higher in patients with endometriosis compared to women without endometriosis PMID: 28322860
    27. IL-37 profile in patients with acute coronary syndrome and the increased IL-37 concentration was associated with a worse clinical in-hospital outcome in STEMI patients undergoing PPCI PMID: 28237549
    28. this study shows that human IL-37 inhibited LPS-induced mouse osteoclast formation and bone resorption via inhibition of LPS-induced osteoclast related cytokines PMID: 27154248
    29. serum IL-37 and its mRNA expression is increased in Ankylosing spondylitis (AS) patients with special consideration in patient with Osteoporosis and correlates with disease activity and BMD which indicate that IL-37 may provide a novel research target for pathogenesis and therapy of AS. PMID: 28502149
    30. this study shows that macrophage-specific expression of IL-37 in hyperlipidemic mice attenuates atherosclerosis PMID: 29030487
    31. IL-27 and IL-37 limit the induction of particular T cell subsets along with cytokine responses in S. stercoralis infections, which suggest the importance of IL-27 and IL-37 in immune modulation in a chronic helminth infection. PMID: 28874444
    32. constitutive IL-37 secretion by myeloid dendritic cells may serve to maintain an anti-inflammatory milieu at steady state, whereas IL-37 is stored in monocytes to be available for rapid release upon inflammatory encounters. PMID: 27881605
    33. IL-37 regulates autophagy in SMMC-7721 and Huh-7 cells via inhibition of the PI3K/AKT/mTOR signaling pathway. PMID: 28433890
    34. IL-37 inhibited the proliferation of hepatocellular carcinoma SMMC-7721 cells. PMID: 28395710
    35. these findings reveal that intracellular IL-37b is a critical factor in the negative regulation of multiple signaling pathways that modulate the expression of metastasis-related genes PMID: 28092676
    36. IL-37 may be employed as a new molecular target for the therapy and diagnosis of Tuberculosis. PMID: 28076390
    37. IL37 itself reduced IL1beta, IL6 and IL8 production in osteoarthritis chondrocytes, indicating that IL37 is able to induce a counter-regulatory anti-inflammatory feedback loop in chondrocytes. In addition, IL37 dampens catabolic enzyme expression. PMID: 27940589
    38. IL-37 is elevated in AF patients and its expression is closely associated with AF subgroups. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of AF. PMID: 28244597
    39. These results indicate that a decreased IL-37 expression by colon epithelial cells may be an important factor for increasing the recruitment of immune cells and subsequently developing microscopic colitis. PMID: 28044228
    40. reviewed the updated evidence indicating the roles of IL-35 and IL-37 in asthma PMID: 27878686
    41. serum level of IL-37 plays a part in the pathophysiology of multiple myeloma progression. PMID: 27807338
    42. this study shows that IL-37 could decrease both NF-kappaB and ICAM-1 expression upon TLR2 activation in human coronary artery endothelial cells, and that this effect may be due to its inhibition on NF-kappaB PMID: 27233003
    43. Results show that elevated plasma IL-37 level and its associations with anti-Sm, anti-RNP and C3 in systemic lupus erythematosus patients suggest that IL-37 may be implicated in this disease. PMID: 27125292
    44. the present data suggest that rs2723176 SNP of IL-37 is involved in the development of TB infection. PMID: 27761939
    45. this study reviews the role of IL-37 as a key suppressor of asthma mediated by mast cells PMID: 27982737
    46. In the discovery phase, two nonsynonymous SNPs (rs3811046 and rs3811047), located in the IL1F7 gene and in an intergenic region, respectively were found to be weakly associated with non-high tension glaucoma cases. PMID: 27533638
    47. CCL22 and IL-37 with a co-localization in the A549 cells inhibited the proliferation PMID: 27499437
    48. increased IL-37 concentrations are associated with the onset of arterial calcification PMID: 27451144
    49. These findings suggest that increased expression of IL-37 was present in eutopic and ectopic endometrium of women with ovarian endometriosis, which might be involved in the inflammatory process of endometriomas. PMID: 26342048
    50. These fi ndings suggest that elevation of HLA-G and IL-37 in hepatitis C virus may play an important role in response to combined therapy with interferon-apha and ribovirin. PMID: 27112970

    显示更多

    收起更多

  • 亚细胞定位：
    Cytoplasm, cytosol. Nucleus. Secreted.
  • 蛋白家族：
    IL-1 family
  • 组织特异性：
    In general, low constitutive expression, if any, in healthy tissues; high expression in inflammatory counterparts, including in synovial tissues from individuals with active rheumatoid arthritis. Isoform A, isoform B and isoform C are expressed in testis,
  • 数据库链接：

    HGNC: 15563

    OMIM: 605510

    KEGG: hsa:27178

    STRING: 9606.ENSP00000263326

    UniGene: Hs.166371